Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-04

Clinical Trial Update: Efficacy of Palmitoylethanolamide-polydatin Combination on Chronic Pelvic Pain in Patients With Endometriosis [NA]

View source ↗

Summary

A completed study assessed the efficacy of a palmitoylethanolamide-polydatin combination for reducing chronic pelvic pain in women with endometriosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Palmitoylethanolamide-polydatin (palmitoylethanolamide-polydatin)

Snippet

Sponsor: University of Cagliari | Conditions: Endometriosis, Chronic Pelvic Pain | NA | Status: COMPLETED